255 related articles for article (PubMed ID: 15721563)
1. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
Lynch ED; Gu R; Pierce C; Kil J
Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
[TBL] [Abstract][Full Text] [Related]
2. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
3. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
[TBL] [Abstract][Full Text] [Related]
4. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
[TBL] [Abstract][Full Text] [Related]
5. Ebselen-mediated protection from single and repeated noise exposure in rat.
Lynch ED; Gu R; Pierce C; Kil J
Laryngoscope; 2004 Feb; 114(2):333-7. PubMed ID: 14755214
[TBL] [Abstract][Full Text] [Related]
6. Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity.
Lynch ED; Gu R; Pierce C; Kil J
Anticancer Drugs; 2005 Jun; 16(5):569-79. PubMed ID: 15846123
[TBL] [Abstract][Full Text] [Related]
7. Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig.
Fechter LD; Liu Y; Pearce TA
Toxicol Appl Pharmacol; 1997 Jan; 142(1):47-55. PubMed ID: 9007033
[TBL] [Abstract][Full Text] [Related]
8. Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase.
Kil J; Pierce C; Tran H; Gu R; Lynch ED
Hear Res; 2007 Apr; 226(1-2):44-51. PubMed ID: 17030476
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis.
Kohn S; Fradis M; Pratt H; Zidan J; Podoshin L; Robinson E; Nir I
Laryngoscope; 1988 Aug; 98(8 Pt 1):865-71. PubMed ID: 3398664
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats.
Dhanarajan R; Abraham P; Isaac B
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):267-72. PubMed ID: 16930301
[TBL] [Abstract][Full Text] [Related]
11. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
12. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
Feghali JG; Liu W; Van De Water TR
Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
[TBL] [Abstract][Full Text] [Related]
13. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
14. The effects of ebselen on cisplatin and diethyldithiocarbamate (DDC) cytotoxicity in rat hippocampal astrocytes.
Hardej D; Trombetta LD
Toxicol Lett; 2002 May; 131(3):215-26. PubMed ID: 11992741
[TBL] [Abstract][Full Text] [Related]
15. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system.
Husain K; Morris C; Whitworth C; Trammell GL; Rybak LP; Somani SM
Mol Cell Biochem; 1998 Jan; 178(1-2):127-33. PubMed ID: 9546591
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
Li G; Liu W; Frenz D
Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
[TBL] [Abstract][Full Text] [Related]
17. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
[TBL] [Abstract][Full Text] [Related]
18. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
[TBL] [Abstract][Full Text] [Related]
19. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
20. Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats.
He M; Xing S; Yang B; Zhao L; Hua H; Liang Z; Zhou W; Zeng J; Pei Z
Brain Res; 2007 Nov; 1181():83-92. PubMed ID: 17920569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
